A Phase 3, Open-Label Period Followed by a Randomized, Double-blind Placebo-controlled Study of the Analgesic Efficacy of Extended-release Hydrocodone/Acetaminophen (Vicodin CR) Compared to Placebo in Subjects With Chronic Low Back Pain
Phase of Trial: Phase III
Latest Information Update: 26 Dec 2013
At a glance
- Drugs Hydrocodone/paracetamol (Primary)
- Indications Back pain
- Focus Registrational; Therapeutic Use
- Sponsors Abbott Laboratories
- 03 Jan 2013 Actual end date change from Apr 2009 to Mar 2009 as reported by ClinicalTrials.gov.
- 03 Jan 2013 Actual initiation date changed from Aug 2008 to Sep 2008 as reported by ClinicalTrials.gov.
- 15 May 2009 Planned number of patients changed from 200 to 223 as reported by ClinicalTrials.gov record.